Kemmx is committed to bringing novel pain and anti-inflammatory medicines to those who suffer from chronic pain.
Kemmx has identitified small molecules that penetrate the skin to provide local pain relief.
Kemmx has been supported by the NIH Bridging Interventional Development Gaps (BrIDGs) program: https://ncats.nih.gov/bridgs/projects/complete/small-molecule-treatment-rheumatoid-arthritis
Sign up to hear from us.
Pain relief by glutaminase inhibition: US Patent 7,288,246
Innovative topical medicine for surgical sites that has Triple A function: 1) Antibiotic; 2) Analgesic; 3) Anti-inflammatory